Gapping down
In reaction to earnings/guidance:
- NUE -5.1%, FLS -2.5%, LICY -0.5%
Other news:
- ALT -51% (reports Phase 1b Clinical Trial of Pemvidutide in Subjects with NAFLD)
- PNT -8.6% (prices offering of 13.9 mln shares of common stock at $9.00 per share)
- TWTR -1.4% (stockholders approve merger agreement with Elon Musk)
- AKRO -1.3% ($175 mln common stock offering)
- CPA -1% (reports August traffic)
Analyst comments:
- SQ -4.1% (downgraded to Underperform from Outperform at Evercore ISI)
- UNP -3.2% (downgraded to Mkt Perform from Outperform at Bernstein)
- AVTR -1.8% (downgraded to Market Perform from Outperform at Cowen)